Proton Magnetic Resonance Spectroscopy in Multiple Sclerosis

Authors

Balasrinivasa R Sajja
Jerry S Wolinsky
Ponnada A Narayana

Language

English

Publication Date

2-1-2009

Journal

Neuroimaging Clinics of North America

DOI

10.1016/j.nic.2008.08.002

PMID

19064199

PMCID

PMC2615006

PubMedCentral® Posted Date

2-1-2010

PubMedCentral® Full Text Version

Author MSS

Abstract

Proton magnetic resonance spectroscopy ((1)H-MRS) provides tissue metabolic information in vivo. This article reviews the role of MRS-determined metabolic alterations in lesions, normal-appearing white matter, gray matter, and spinal cord in advancing our knowledge of pathologic changes in multiple sclerosis (MS). In addition, the role of MRS in objectively evaluating therapeutic efficacy is reviewed. This potential metabolic information makes MRS a unique tool to follow MS disease evolution, understand its pathogenesis, evaluate the disease severity, establish a prognosis, and objectively evaluate the efficacy of therapeutic interventions.

Keywords

Brain, Humans, Magnetic Resonance Spectroscopy, Multiple Sclerosis

Published Open-Access

yes

Recommended Citation

Balasrinivasa R Sajja, Jerry S Wolinsky, and Ponnada A Narayana, "Proton Magnetic Resonance Spectroscopy in Multiple Sclerosis" (2009). Faculty, Staff and Student Publications. 102.
https://digitalcommons.library.tmc.edu/uthmed_docs/102